BZ
Kanzhun Limited
BZ offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has a slight edge over BZ overall, supported by stronger modeled upside and lower modeled downside.
BZ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
BZ's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 8.6x | $12.49 | — |
| Cheap | 16x | $23.16 | +85% |
| Fair | 33x | $47.95 | +284% |
| Expensive | 95x | $139 | +1013% |
Historical ranges are pointers, not guarantees.
BZ has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BZ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BZ, with profitability improving.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
BZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.46 | +103% |
| Q1 2026 | $1.07 | +73% |
| Q4 2025 | $0.88 | +69% |
| Q3 2025 | $0.82 | +71% |
| Q2 2025 | $0.72 | +53% |
| Q1 2025 | $0.62 | +41% |
| Q4 2024 | $0.52 | +44% |
| Q3 2022 | $0.17 | +$0.86 |
BZ has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
BZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $360M | +14% |
| Q1 2026 | $308.6M | +6.9% |
| Q4 2025 | $311.9M | +14% |
| Q3 2025 | $324.6M | +13% |
| Q2 2025 | $315.5M | +9.7% |
| Q1 2025 | $288.6M | +13% |
| Q4 2024 | $273.7M | +15% |
| Q3 2024 | $286.9M | +19% |
BZ has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 36% | +5 points |
| Q1 2026 | 30% | +7.2 points |
| Q4 2025 | 33% | +12 points |
| Q3 2025 | 32% | +15 points |
| Q2 2025 | 31% | +12 points |
| Q1 2025 | 23% | +17 points |
| Q4 2024 | 21% | +6.8 points |
| Q3 2024 | 17% | +1 points |
BZ has the edge over CAT on profitability, with a higher operating margin.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
BZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $141.8M | -13% |
| Q1 2026 | $178.6M | +23% |
| Q4 2025 | $180.8M | +1104% |
| Q3 2025 | $176.2M | +45% |
| Q2 2025 | $163.3M | +100% |
| Q1 2025 | $145.1M | +105% |
| Q4 2024 | $15M | +$19.3M |
| Q3 2024 | $121.9M | 0% |
BZ has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
BZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -11.2M shares |
| 1 year | +3.4% | +15M shares |
| 3 years | +2.8% | +12.7M shares |
| 5 years | +16% | +62.9M shares |
| Available history | +30% | +107M shares |
BZ has 463M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $6.3M |
| Q3 2025 | — |
| Q2 2025 | $1.1M |
| Q1 2025 | $14M |
| Q4 2024 | $247.9M |
| Q3 2024 | — |
BZ spent $6M buying back its own shares over the past year, down 98% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over BZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
| Q3 2024 | -1.2x | Net Cash |
BZ has more cash than debt.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over BZ on leverage, with a lower net debt burden relative to earnings.
BZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 40.4 | Neutral |
BZ's weekly RSI is 38 (neutral) and its Stochastic is 40 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BZ PE vs Industrials Sector
| Metric | BZ | Sector median | Relative |
|---|---|---|---|
| PE | 8.6x | 24x | 64% below |
| PE % | 0 | 62 | 62 pts below |
BZ has the edge over CAT on valuation relative to its sector.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 20% below |
| 20 week MA | $15.6 | 20% below |
| 50 week MA | $15.9 | 21% below |
| 100 week MA | $17.2 | 28% below |
| 200 week MA | $17.0 | 27% below |
BZ is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BZ on trend strength, trading above more of its moving averages.
BZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $37.2 | $33.0 | -11% |
| 2022 | $33.0 | $19.2 | -42% |
| 2023 | $19.2 | $16.6 | -13% |
| 2024 | $16.6 | $13.9 | -16% |
| 2025 | $13.9 | $21.1 | +52% |
| 2026 YTD | $21.1 | $12.5 | -41% |
BZ has finished lower in four of the last five years. It's down 41% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BZ on returns for 2026, with the stronger performance.